In terms of tissue-based studies, CTNNB1-mutated HCC has been reported to induce an immune-cold tumor microenvironment (TME) with a lack of immune cell infiltration, promoting resistance to ICI monotherapy [61]. This evidence concerns the gene CTNNB1 and neoplasm.